B&G Foods Reports Financial Results for Third Quarter 2021
B&G Foods reported a 3.9% increase in net sales for Q3 2021, reaching $515.0 million, driven by the Crisco acquisition. Compared to Q3 2020, diluted earnings per share decreased 55.6% to $0.32, and net income fell 55.7% to $20.7 million. Adjusted EBITDA decreased 8.1% to $96.2 million. Additionally, base business net sales declined 10.5%. The company reaffirmed its full-year net sales guidance at $2.05 billion to $2.10 billion, with adjusted EBITDA guidance set at $358.0 million to $365.0 million.
- Q3 2021 net sales up 3.9% to $515.0 million due to Crisco acquisition.
- Base business net sales were 9.2% higher than pre-pandemic levels.
- Reaffirmation of full-year fiscal 2021 net sales guidance at $2.05 billion to $2.10 billion.
- Q3 diluted EPS decreased 55.6% to $0.32.
- Q3 net income fell 55.7% to $20.7 million.
- Adjusted EBITDA decreased 8.1% to $96.2 million.
- Base business net sales decreased 10.5% in Q3 2021.
Third Quarter 2021 Summary (vs. Third Quarter of 2020 and vs. Third Quarter 2019 for two-year annual compound growth rates, where applicable):
-
Net sales increased
3.9% to , driven by the Crisco acquisition, partially offset by comparisons against the extraordinary demand resulting from the COVID-19 pandemic during the third quarter of 2020 and one fewer reporting week in the third quarter of 2021.$515.0 million -
Net sales and base business net sales1 for the third quarter of 2021 were
26.7% and9.2% higher than pre-pandemic net sales and base business net sales for the third quarter of 2019. On a two-year compound annual growth basis, relative to pre-pandemic levels, third quarter net sales increased12.6% and base business net sales increased4.5% . -
Diluted earnings per share2 decreased
55.6% to and adjusted diluted earnings per share1 decreased$0.32 25.7% to . On a two-year compound annual growth basis, third quarter adjusted diluted earnings per share increased$0.55 1.5% . -
Net income2 decreased
55.7% to and adjusted net income1 decreased$20.7 million 24.5% to . On a two-year compound annual growth basis, third quarter adjusted net income increased$36.2 million 1.8% . -
Adjusted EBITDA1 decreased
8.1% to . On a two-year compound annual growth basis, third quarter adjusted EBITDA increased$96.2 million 5.6% .
Guidance for Full Year Fiscal 2021
-
Net sales guidance reaffirmed at a range of
to$2.05 billion .$2.10 billion -
Adjusted EBITDA guidance set at a range of
to$358.0 million .$365.0 million
Commenting on the results,
_________________ | ||
1 |
Please see “About Non-GAAP Financial Measures and Items Affecting Comparability” below for the definition of the non-GAAP financial measures “base business net sales,” “adjusted diluted earnings per share,” “adjusted net income,” “EBITDA,” “adjusted EBITDA” and “adjusted EBITDA before COVID-19 expenses,” as well as information concerning certain items affecting comparability and reconciliations of the non-GAAP terms to the most comparable GAAP financial measures. |
|
2 |
Diluted earnings per share and net income for the third quarter and first three quarters of 2021 were negatively impacted by |
Financial Results for the Third Quarter of 2021
Net sales for the third quarter of 2021 increased
Base business net sales for the third quarter of 2021 decreased
Net sales of Ortega increased
Net sales for the third quarter of 2021 for Green Giant, spices & seasonings,
Gross profit was
_________________ | ||
3 |
Includes the spices & seasoning brands acquired in the fourth quarter of 2016, as well as the Company’s legacy spices & seasonings brands, such as Dash and Ac’cent. |
During the third quarter of 2021, the Company’s gross profit was negatively impacted by higher than expected input cost inflation, including materially increased costs for raw materials and transportation. The Company expects input cost inflation to be materially higher in the fourth quarter of 2021 than it was in the fourth quarter of 2020 and that cost inflation will continue to have a significant industry-wide impact during fiscal 2022. The Company is attempting to mitigate the impact of inflation on its gross profit by locking in prices through short-term supply contracts and advance commodities purchase agreements and by implementing cost saving measures. The Company has also announced list price increases and has reduced trade promotions to its customers for certain of its products. However, increases in the prices the Company charges its customers generally lag behind rising input costs. As such, the Company does not expect to fully offset the incremental costs that the Company is facing in fiscal 2021 and expects continued cost inflation in fiscal 2022.
Selling, general and administrative expenses increased
Net interest expense increased
The Company’s net income was
For the third quarter of 2021, adjusted EBITDA was
For the third quarter of 2021, adjusted EBITDA before COVID-19 expenses1 was
Financial Results for the First Three Quarters of 2021
Net sales for the first three quarters of 2021 increased
Base business net sales1 for the first three quarters of 2021 decreased
Net sales of the Company’s spices & seasonings3 increased
Net sales for the first three quarters of 2021 for spices & seasonings, Ortega, Green Giant,
Gross profit was
_________________ | ||
4 |
Compares net sales of Clabber Girl from |
During the first three quarters of 2021, the Company’s gross profit was negatively impacted by higher than expected input cost inflation, including materially increased costs for raw materials and transportation. The Company expects input cost inflation to be materially higher in the fourth quarter of 2021 than it was in the fourth quarter of 2020 and that cost inflation will continue to have a significant industry-wide impact during fiscal 2022. The Company is attempting to mitigate the impact of inflation on its gross profit by locking in prices through short-term supply contracts and advance commodities purchase agreements and by implementing cost saving measures. The Company has also announced list price increases and has reduced trade promotions to its customers for certain of its products. However, increases in the prices the Company charges its customers generally lag behind rising input costs. As such, the Company does not expect to fully offset the incremental costs that it is facing in fiscal 2021 and expects continued cost inflation in fiscal 2022.
Selling, general and administrative expenses increased
Net interest expense increased
The Company’s net income was
For the first three quarters of 2021, adjusted EBITDA was
For the first three quarters of 2021, adjusted EBITDA before COVID-19 expenses was
Sale of
As previously announced, the Company reached an agreement during the third quarter of 2021 to sell its
The annual cash payments for the multi-employer pension plan withdrawal liability are expected to be more than offset by cost savings resulting from the transition of the manufacturing operations, and the remainder of the cash portion of the one-time charges are expected to be largely offset by the proceeds of the sale of the
Full Year Fiscal 2021 Guidance
Conference Call
About Non-GAAP Financial Measures and Items Affecting Comparability
“Adjusted net income” (net income adjusted for certain items that affect comparability), “adjusted diluted earnings per share,” (diluted earnings per share adjusted for certain items that affect comparability), “base business net sales” (net sales without the impact of acquisitions until the acquisitions are included in both comparable periods and without the impact of discontinued or divested brands), “EBITDA” (net income before net interest expense, income taxes, depreciation and amortization and loss on extinguishment of debt), “adjusted EBITDA” (EBITDA as adjusted for cash and non-cash acquisition/divestiture-related expenses, gains and losses (which may include third party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up and gains and losses on sale of assets) and non-recurring expenses, gains and losses) and “adjusted EBITDA before COVID-19 expenses” (adjusted EBITDA as adjusted for COVID-19 expenses5) are “non-GAAP financial measures.” A non-GAAP financial measure is a numerical measure of financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles in
The Company uses non-GAAP financial measures to adjust for certain items that affect comparability. This information is provided in order to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Because the Company cannot predict the timing and amount of these items that affect comparability, management does not consider these items when evaluating the Company’s performance or when making decisions regarding allocation of resources.
Additional information regarding EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses, and a reconciliation of EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses to net income and to net cash provided by operating activities, is included below for the third quarter and first three quarters of 2021 and 2020, along with the components of EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses. Also included below are reconciliations of the non-GAAP terms adjusted net income, adjusted diluted earnings per share and base business net sales to the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive income, changes in stockholders’ equity and cash flows.
About
Based in
_________________ | ||
5 |
COVID-19 expenses include temporary enhanced compensation from |
Forward-Looking Statements
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” The forward-looking statements contained in this press release include, without limitation, statements related to B&G Foods’ expectations regarding net sales, consumer trends, input cost inflation, list price increases, trade spend initiatives, margins, and the Company’s overall expectations for the remainder of fiscal 2021 and beyond; B&G Foods’ planned sale of the
|
|||||
Consolidated Balance Sheets |
|||||
(In thousands, except share and per share data) |
|||||
(Unaudited) |
|||||
|
|
|
|
|
|
|
|
|
|
||
|
2021 |
|
2021 |
||
Assets |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
$ |
27,062 |
|
$ |
52,182 |
Trade accounts receivable, net |
|
179,655 |
|
|
132,935 |
Inventories |
|
670,305 |
|
|
492,804 |
Assets held for sale |
|
3,262 |
|
|
— |
Prepaid expenses and other current assets |
|
45,153 |
|
|
43,619 |
Income tax receivable |
|
7,341 |
|
|
15,761 |
Total current assets |
|
932,778 |
|
|
737,301 |
|
|
|
|
|
|
Property, plant and equipment, net |
|
346,537 |
|
|
371,854 |
Operating lease right-of-use assets |
|
54,700 |
|
|
32,216 |
|
|
644,869 |
|
|
644,747 |
Other intangible assets, net |
|
1,955,597 |
|
|
1,971,326 |
Other assets |
|
6,240 |
|
|
5,948 |
Deferred income taxes |
|
5,417 |
|
|
4,178 |
Total assets |
$ |
3,946,138 |
|
$ |
3,767,570 |
|
|
|
|
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Trade accounts payable |
$ |
202,675 |
|
$ |
126,537 |
Accrued expenses |
|
54,437 |
|
|
77,460 |
Current portion of operating lease liabilities |
|
11,060 |
|
|
11,034 |
Income tax payable |
|
463 |
|
|
101 |
Dividends payable |
|
30,826 |
|
|
30,520 |
Total current liabilities |
|
299,461 |
|
|
245,652 |
|
|
|
|
|
|
Long-term debt |
|
2,406,830 |
|
|
2,334,086 |
Deferred income taxes |
|
309,698 |
|
|
293,121 |
Long-term operating lease liabilities, net of current portion |
|
46,535 |
|
|
23,959 |
Other liabilities |
|
52,992 |
|
|
38,875 |
Total liabilities |
|
3,115,516 |
|
|
2,935,693 |
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
Preferred stock, |
|
— |
|
|
— |
Common stock, |
|
649 |
|
|
643 |
Additional paid-in capital |
|
— |
|
|
— |
Accumulated other comprehensive loss |
|
(35,405) |
|
|
(35,594) |
Retained earnings |
|
865,378 |
|
|
866,828 |
Total stockholders’ equity |
|
830,622 |
|
|
831,877 |
Total liabilities and stockholders’ equity |
$ |
3,946,138 |
|
$ |
3,767,570 |
|
|||||||||||
Consolidated Statements of Operations |
|||||||||||
(In thousands, except per share data) |
|||||||||||
(Unaudited) |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||
Net sales |
$ |
514,965 |
|
$ |
495,759 |
|
$ |
1,484,474 |
|
$ |
1,457,668 |
Cost of goods sold |
|
409,300 |
|
|
359,733 |
|
|
1,149,425 |
|
|
1,082,625 |
Gross profit |
|
105,665 |
|
|
136,026 |
|
|
335,049 |
|
|
375,043 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
46,409 |
|
|
43,395 |
|
|
143,864 |
|
|
127,715 |
Amortization expense |
|
5,396 |
|
|
4,735 |
|
|
16,231 |
|
|
14,197 |
Operating income |
|
53,860 |
|
|
87,896 |
|
|
174,954 |
|
|
233,131 |
|
|
|
|
|
|
|
|
|
|
|
|
Other income and expenses: |
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
26,630 |
|
|
26,430 |
|
|
80,312 |
|
|
77,318 |
Other income |
|
(1,130) |
|
|
(702) |
|
|
(3,338) |
|
|
(1,856) |
Income before income tax expense |
|
28,360 |
|
|
62,168 |
|
|
97,980 |
|
|
157,669 |
Income tax expense |
|
7,613 |
|
|
15,355 |
|
|
25,804 |
|
|
37,853 |
Net income |
$ |
20,747 |
|
$ |
46,813 |
|
$ |
72,176 |
|
$ |
119,816 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
64,845 |
|
|
64,217 |
|
|
64,735 |
|
|
64,133 |
Diluted |
|
65,493 |
|
|
64,801 |
|
|
65,371 |
|
|
64,434 |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.32 |
|
$ |
0.73 |
|
$ |
1.11 |
|
$ |
1.87 |
Diluted |
$ |
0.32 |
|
$ |
0.72 |
|
$ |
1.10 |
|
$ |
1.86 |
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per share |
$ |
0.475 |
|
$ |
0.475 |
|
$ |
1.425 |
|
$ |
1.425 |
|
||||||||||||
Items Affecting Comparability |
||||||||||||
Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Before COVID-19 Expenses to Net Income and to Net Cash Provided by Operating Activities |
||||||||||||
(In thousands) |
||||||||||||
(Unaudited) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||
Net income |
|
$ |
20,747 |
|
$ |
46,813 |
|
$ |
72,176 |
|
$ |
119,816 |
Income tax expense |
|
|
7,613 |
|
|
15,355 |
|
|
25,804 |
|
|
37,853 |
Interest expense, net |
|
|
26,630 |
|
|
26,430 |
|
|
80,312 |
|
|
77,318 |
Depreciation and amortization |
|
|
20,728 |
|
|
15,589 |
|
|
61,257 |
|
|
46,508 |
EBITDA(1) |
|
|
75,718 |
|
|
104,187 |
|
|
239,549 |
|
|
281,495 |
Acquisition/divestiture-related and non-recurring expenses(2) |
|
|
6,388 |
|
|
423 |
|
|
14,217 |
|
|
6,403 |
Amortization of acquisition-related inventory step-up(3) |
|
|
— |
|
|
— |
|
|
5,054 |
|
|
— |
Accrual for expected multi-employer pension plan withdrawal liability(4) |
|
|
14,056 |
|
|
— |
|
|
14,056 |
|
|
— |
Adjusted EBITDA(1) |
|
|
96,162 |
|
|
104,610 |
|
|
272,876 |
|
|
287,898 |
COVID-19 expenses(5) |
|
|
209 |
|
|
4,786 |
|
|
4,299 |
|
|
9,225 |
Adjusted EBITDA before COVID-19 expenses(1) |
|
|
96,371 |
|
|
109,396 |
|
|
277,175 |
|
|
297,123 |
Income tax expense |
|
|
(7,613) |
|
|
(15,355) |
|
|
(25,804) |
|
|
(37,853) |
Interest expense, net |
|
|
(26,630) |
|
|
(26,430) |
|
|
(80,312) |
|
|
(77,318) |
Acquisition/divestiture-related and non-recurring expenses(2) |
|
|
(6,388) |
|
|
(423) |
|
|
(14,217) |
|
|
(6,403) |
Amortization of acquisition-related inventory step-up(3) |
|
|
— |
|
|
— |
|
|
(5,054) |
|
|
— |
Accrual for expected multi-employer pension plan withdrawal liability(4) |
|
|
(14,056) |
|
|
— |
|
|
(14,056) |
|
|
— |
Net loss (gain) on sales and disposals of property, plant and equipment |
|
|
30 |
|
|
— |
|
|
— |
|
|
(61) |
Deferred income taxes |
|
|
3,524 |
|
|
5,587 |
|
|
14,894 |
|
|
19,868 |
Amortization of deferred debt financing costs and bond discount/premium |
|
|
1,155 |
|
|
1,965 |
|
|
3,444 |
|
|
3,764 |
Share-based compensation expense |
|
|
1,103 |
|
|
2,817 |
|
|
3,228 |
|
|
7,061 |
Changes in assets and liabilities, net of effects of business combinations |
|
|
(100,466) |
|
|
(86,834) |
|
|
(142,213) |
|
|
35,347 |
Net cash provided by (used in) operating activities |
|
$ |
(53,179) |
|
$ |
(14,063) |
|
$ |
12,786 |
|
$ |
232,303 |
_________________ | ||
(1) |
EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are non-GAAP financial measures used by management to measure operating performance. A non-GAAP financial measure is defined as a numerical measure of the Company’s financial performance that excludes or includes amounts so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive income, changes in stockholders’ equity and cash flows. The Company defines EBITDA as net income before net interest expense, income taxes, depreciation and amortization and loss on extinguishment of debt. The Company defines adjusted EBITDA as EBITDA adjusted for cash and non-cash acquisition/divestiture-related expenses, gains and losses (which may include third party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up, and gains and losses on the sale of assets); and non-recurring expenses, gains and losses, including severance and other expenses relating to the separation of the Company’s former chief executive officer in fiscal 2020, a workforce reduction in fiscal 2019 and an accrual for the estimated present value of a multi-employer pension plan withdrawal liability. The Company defines adjusted EBITDA before COVID-19 expenses as adjusted EBITDA adjusted for COVID-19 expenses. |
|
|
|
|
|
Management believes that it is useful to eliminate these items because it allows management to focus on what it deems to be a more reliable indicator of ongoing operating performance and the Company’s ability to generate cash flow from operations. The Company uses EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses in the Company’s business operations to, among other things, evaluate the Company’s operating performance, develop budgets and measure the Company’s performance against those budgets, determine employee bonuses and evaluate the Company’s cash flows in terms of cash needs. The Company also presents EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses because the Company believes they are useful indicators of the Company’s historical debt capacity and ability to service debt and because covenants in the Company’s credit agreement and the Company’s senior notes indentures contain ratios based on these measures. As a result, reports used by internal management during monthly operating reviews feature the EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses metrics. However, management uses these metrics in conjunction with traditional GAAP operating performance and liquidity measures as part of its overall assessment of company performance and liquidity, and therefore does not place undue reliance on these measures as its only measures of operating performance and liquidity. |
|
|
|
|
|
EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are not recognized terms under GAAP and do not purport to be alternatives to operating income, net income or any other GAAP measure as an indicator of operating performance. EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are not complete net cash flow measures because EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are measures of liquidity that do not include reductions for cash payments for an entity’s obligation to service its debt, fund its working capital, capital expenditures and acquisitions and pay its income taxes and dividends. Rather, EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are potential indicators of an entity’s ability to fund these cash requirements. EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are not complete measures of an entity’s profitability because they do not include certain costs and expenses and gains and losses described above. Because not all companies use identical calculations, this presentation of EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses may not be comparable to other similarly titled measures of other companies. However, EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses can still be useful in evaluating the Company’s performance against the Company’s peer companies because management believes these measures provide users with valuable insight into key components of GAAP amounts. |
|
|
|
|
(2) |
Acquisition/divestiture-related and non-recurring expenses for the third quarter and first three quarters of 2021 of |
|
|
|
|
(3) |
For the first three quarters of 2021, amortization of acquisition-related inventory step-up of |
|
|
|
|
(4) |
During the third quarter of 2021, the Company reached an agreement to sell its |
|
|
|
|
(5) |
COVID-19 expenses of |
|
||||||||||||
Items Affecting Comparability |
||||||||||||
Reconciliation of Adjusted Net Income and Adjusted Diluted Earnings per Share to Net Income |
||||||||||||
(In thousands, except per share data) |
||||||||||||
(Unaudited) |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||
Net income |
|
$ |
20,747 |
|
$ |
46,813 |
|
$ |
72,176 |
|
$ |
119,816 |
Acquisition/divestiture-related and non-recurring expenses, net of tax(1) |
|
|
4,823 |
|
|
319 |
|
|
10,734 |
|
|
4,834 |
Accelerated amortization of deferred debt financing costs |
|
|
— |
|
|
808 |
|
|
— |
|
|
808 |
Tax benefit(2) |
|
|
— |
|
|
— |
|
|
— |
|
|
(2,258) |
Amortization of acquisition-related inventory step-up, net of tax(3) |
|
|
— |
|
|
— |
|
|
3,816 |
|
|
— |
Accrual for expected multi-employer pension plan withdrawal liability(4) |
|
|
10,612 |
|
|
— |
|
|
10,612 |
|
|
— |
Adjusted net income |
|
$ |
36,182 |
|
$ |
47,940 |
|
$ |
97,338 |
|
$ |
123,200 |
Adjusted diluted earnings per share |
|
$ |
0.55 |
|
$ |
0.74 |
|
$ |
1.49 |
|
$ |
1.91 |
_________________ | ||
(1) |
Acquisition/divestiture-related and non-recurring expenses for the third quarter and first three quarters of 2021 primarily includes acquisition and integration expenses for the Crisco acquisition and certain cost savings initiatives. Acquisition/divestiture-related and non-recurring expenses for the third quarter and first three quarters of 2020 primarily includes acquisition and integration expenses for the Clabber Girl and Farmwise acquisitions, and severance and other expenses primarily relating to a workforce reduction in fiscal 2019 and certain cost savings initiatives. |
|
|
|
|
(2) |
The first three quarters of 2020 includes a |
|
|
|
|
(3) |
For the first three quarters of 2021, amortization of acquisition-related inventory step-up of |
|
|
|
|
(4) |
During the third quarter of 2021, the Company reached an agreement to sell its |
Items Affecting Comparability
Reconciliation of Base Business
(In thousands)
(Unaudited)
2021 Compared to 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||
Net sales |
|
$ |
514,965 |
|
$ |
495,759 |
|
$ |
1,484,474 |
|
$ |
1,457,668 |
Net sales from acquisitions(2) |
|
|
(71,217) |
|
|
— |
|
|
(187,915) |
|
|
— |
Base business net sales |
|
$ |
443,748 |
|
$ |
495,759 |
|
$ |
1,296,559 |
|
$ |
1,457,668 |
2021 Compared to 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Ended |
|
First Three Quarters Ended |
||||||||
|
|
|
|
|
|
|
|
|
||||
|
|
2021 |
|
2019 |
|
2021 |
|
2019 |
||||
Net sales |
|
$ |
514,965 |
|
$ |
406,311 |
|
$ |
1,484,474 |
|
$ |
1,190,242 |
Net sales from acquisitions(3) |
|
|
(71,318) |
|
|
— |
|
|
(213,852) |
|
|
— |
Base business net sales |
|
$ |
443,647 |
|
$ |
406,311 |
|
$ |
1,270,622 |
|
$ |
1,190,242 |
_________________ | ||
(1) |
Base business net sales is a non-GAAP financial measure used by management to measure operating performance. The Company defines base business net sales as the Company’s net sales excluding (1) the net sales of acquisitions until the net sales from such acquisitions are included in both comparable periods and (2) net sales of discontinued or divested brands. The portion of current period net sales attributable to recent acquisitions for which there is no corresponding period in the comparable period of the prior year is excluded. For each acquisition, the excluded period starts at the beginning of the most recent fiscal period being compared and ends on the first anniversary of the acquisition date. For discontinued or divested brands, the entire amount of net sales is excluded from each fiscal period being compared. The Company has included this financial measure because management believes it provides useful and comparable trend information regarding the results of the Company’s business without the effect of the timing of acquisitions and the effect of discontinued or divested brands. |
|
|
|
|
(2) |
Primarily reflects |
|
|
|
|
(3) |
Primarily reflects (a) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104006293/en/
Investor Relations:
866.211.8151
Media Relations:
203.682.8214
Source:
FAQ
What were BGS's Q3 2021 financial results?
How did the Crisco acquisition impact BGS's sales?
What is the net income for BGS in Q3 2021?
What guidance has BGS provided for full-year fiscal 2021?